Cyber Incident Victim: SYNLAB France
Date:
May 2023
Location:
France
Summary
SYNLAB France experienced a cybersecurity incident impacting four of its laboratories, three of which worked with a hospital and three partner clinics. The attack compromised administrative personal data and older health information for a very small number of patients. The company took immediate action to block the attackers' ports, halting further data exfiltration. It notified the relevant healthcare institutions and competent authorities, including filing a formal complaint. There is no indication the compromised information has been misused.
| CIA Posture | Motives | Tactics, Techniques & Procedures |
|---|---|---|
| Available to members | 1 motive | 1 technique |
| Threat Actors | Type | Location |
|---|---|---|
| 0 actors | Available to members | Available to members |
Description
On or around May 31, 2023, SYNLAB France became aware of a cybersecurity incident and took immediate measures to contain it. The organization blocked the ports used by the attackers, an action which immediately halted any further possibility of data exfiltration. This swift response was the initial step in a broader containment strategy aimed at limiting the damage from the malicious act. The primary focus was to sever the attackers' access to the network and prevent any ongoing or additional data extraction, thereby securing the systems from further compromise.

The investigation into the incident determined its scope was limited. SYNLAB France certified that the malicious act concerned only four of its laboratories. Among these four affected laboratories, three were facilities that worked directly with a hospital and three partner clinics. This indicates the incident was not a system-wide compromise of all SYNLAB France operations but was instead confined to a specific subset of its network infrastructure tied to these particular partnerships. The impact on patient data was also assessed as being contained to a very small number of individuals, suggesting a targeted rather than a broad, indiscriminate attack.
The type of data involved in the incident was specifically identified. The compromised information consisted of administrative personal data. This category typically includes identifiers such as names, addresses, and contact information, but not financial details like credit card numbers. Furthermore, the data involved was described as old health data. The characterization of the information as historical suggests it was not the most current or active patient medical records, but rather archived or older information stored within the systems of the affected laboratories.
A critical point emphasized by SYNLAB France was that there was no evidence to suggest the stolen data had been misused. The company stated that, at the time of their communication, nothing allowed them to conclude there had been any malicious or diverted use of the information that was captured. This absence of evidence regarding misuse was a key part of their assessment of the immediate risk posed by the breach, though it did not diminish the fact that a theft of sensitive information had occurred.
The response protocol included mandatory notifications to relevant authorities and partners. SYNLAB France concomitantly informed the concerned healthcare establishments about the breach. In parallel, the company notified the competent authorities, specifically naming the Commission Nationale de l’Informatique et des Libertés (CNIL), which is the French data protection authority. This action is a regulatory requirement under data protection laws following a personal data breach. Beyond the mandatory reporting, a formal complaint was also filed with the concerned services, which typically refers to law enforcement agencies such as the police or gendarmerie, initiating a legal process to investigate the crime.
Ongoing communication and coordination with affected partners were established as part of the response. SYNLAB France immediately made contact with the concerned establishments following the discovery of the incident. The company maintained constant relations with these partners within the framework of their strict security procedures. This ongoing dialogue was crucial for managing the fallout, coordinating any necessary remedial actions, and ensuring a unified response to the incident across all involved organizations.
SYNLAB France framed its response within its core values, placing the confidentiality of health data and the protection of privacy at the forefront of its mission. The company stated it responds daily to high standards of security, underscoring its commitment to data protection. This statement served to reassure stakeholders of its dedication to maintaining rigorous security practices despite the incident. The commitment to transparency was explicitly stated as a guiding principle for their communications regarding the malicious act of which they were a victim.
The final phase of the immediate response involved a commitment to future action. SYNLAB France pledged to continue taking all necessary measures to protect the personal data of its partner establishments and patients. This forward-looking statement indicated the response was not concluded with the initial containment and notifications but would involve ongoing efforts to strengthen defenses and prevent future occurrences. The promise of continued transparent communication reflected an understanding that managing the incident was an ongoing process that would evolve as more information became available or if the situation changed.
